NO20001178L - Expression of gonadotropins in Dictyostelium - Google Patents
Expression of gonadotropins in DictyosteliumInfo
- Publication number
- NO20001178L NO20001178L NO20001178A NO20001178A NO20001178L NO 20001178 L NO20001178 L NO 20001178L NO 20001178 A NO20001178 A NO 20001178A NO 20001178 A NO20001178 A NO 20001178A NO 20001178 L NO20001178 L NO 20001178L
- Authority
- NO
- Norway
- Prior art keywords
- gonadotropins
- dictyostelium
- expression
- gonadotropin
- excreted
- Prior art date
Links
- 102000006771 Gonadotropins Human genes 0.000 title abstract 5
- 108010086677 Gonadotropins Proteins 0.000 title abstract 5
- 239000002622 gonadotropin Substances 0.000 title abstract 5
- 229940094892 gonadotropins Drugs 0.000 title abstract 4
- VUDQSRFCCHQIIU-UHFFFAOYSA-N 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one Chemical compound CCCCCC(=O)C1=C(O)C(Cl)=C(OC)C(Cl)=C1O VUDQSRFCCHQIIU-UHFFFAOYSA-N 0.000 title abstract 3
- 241000224495 Dictyostelium Species 0.000 title abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Det er beskrevet gonadotropiner uttrykt i Dictyostelium. Gonadotropiner blir utskilt i en biologisk.aktiv form. Ekspresjon av gonadotropiner i Dictyostelium utgjør en lett måte å selektere for gonadotropinmutanter på.Gonadotropins expressed in Dictyostelium have been described. Gonadotropins are excreted in a biologically active form. Expression of gonadotropins in Dictyostelium provides an easy way to select for gonadotropin mutants.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97202757 | 1997-09-08 | ||
PCT/EP1998/005717 WO1999013081A1 (en) | 1997-09-08 | 1998-09-02 | EXPRESSION OF GONADOTROPINS IN $i(DICTYOSTELIUM) |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20001178D0 NO20001178D0 (en) | 2000-03-07 |
NO20001178L true NO20001178L (en) | 2000-05-05 |
Family
ID=8228713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20001178A NO20001178L (en) | 1997-09-08 | 2000-03-07 | Expression of gonadotropins in Dictyostelium |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1012290A1 (en) |
JP (1) | JP2001515721A (en) |
KR (1) | KR20010023749A (en) |
CN (1) | CN1269834A (en) |
AR (1) | AR013468A1 (en) |
AU (1) | AU746780B2 (en) |
BR (1) | BR9812043A (en) |
CA (1) | CA2302647A1 (en) |
HU (1) | HUP0004599A3 (en) |
IL (1) | IL134589A0 (en) |
NO (1) | NO20001178L (en) |
NZ (1) | NZ502964A (en) |
PL (1) | PL339259A1 (en) |
TR (1) | TR200000618T2 (en) |
WO (1) | WO1999013081A1 (en) |
ZA (1) | ZA987497B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001058493A1 (en) * | 2000-02-11 | 2001-08-16 | Maxygen Aps | Conjugates of follicle stimulating hormones |
WO2002002597A2 (en) * | 2000-06-30 | 2002-01-10 | Maxygen Aps | Peptide extended glycosylated polypeptides |
DE60238490D1 (en) | 2001-09-12 | 2011-01-13 | Merck Serono Sa | USE OF HUMAN CHORIONGONADOTROPIN (HCG) AND LUTEINIZING HORMONE (LH) FOR THE REGULATED HYPERSTIMULATION OF EGGSTUFFS |
AU2002324183B2 (en) * | 2001-09-12 | 2007-10-25 | Merck Serono Sa | Use of hCG and LH in controlled ovarian hyperstimulation |
MEP39208A (en) * | 2001-09-12 | 2011-02-10 | Merck Serono Sa | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
WO2014159813A1 (en) | 2013-03-13 | 2014-10-02 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69535260T2 (en) * | 1994-02-18 | 2007-08-09 | Applied Research Systems Ars Holding N.V. | Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone to increase fertility |
US5691455A (en) * | 1995-10-24 | 1997-11-25 | Akzo Nobel N.V. | Gonadotropins with non-native disulfide bridges |
-
1998
- 1998-08-19 ZA ZA987497A patent/ZA987497B/en unknown
- 1998-09-02 JP JP2000510866A patent/JP2001515721A/en not_active Withdrawn
- 1998-09-02 CN CN98808921A patent/CN1269834A/en active Pending
- 1998-09-02 EP EP98948936A patent/EP1012290A1/en not_active Withdrawn
- 1998-09-02 WO PCT/EP1998/005717 patent/WO1999013081A1/en not_active Application Discontinuation
- 1998-09-02 TR TR2000/00618T patent/TR200000618T2/en unknown
- 1998-09-02 AU AU95381/98A patent/AU746780B2/en not_active Ceased
- 1998-09-02 IL IL13458998A patent/IL134589A0/en unknown
- 1998-09-02 NZ NZ502964A patent/NZ502964A/en unknown
- 1998-09-02 BR BR9812043-3A patent/BR9812043A/en not_active IP Right Cessation
- 1998-09-02 HU HU0004599A patent/HUP0004599A3/en unknown
- 1998-09-02 PL PL98339259A patent/PL339259A1/en not_active Application Discontinuation
- 1998-09-02 KR KR1020007002404A patent/KR20010023749A/en not_active Application Discontinuation
- 1998-09-02 CA CA002302647A patent/CA2302647A1/en not_active Abandoned
- 1998-09-07 AR ARP980104442A patent/AR013468A1/en unknown
-
2000
- 2000-03-07 NO NO20001178A patent/NO20001178L/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR013468A1 (en) | 2000-12-27 |
PL339259A1 (en) | 2000-12-04 |
IL134589A0 (en) | 2001-04-30 |
AU746780B2 (en) | 2002-05-02 |
HUP0004599A2 (en) | 2001-04-28 |
CN1269834A (en) | 2000-10-11 |
NZ502964A (en) | 2001-08-31 |
TR200000618T2 (en) | 2000-09-21 |
ZA987497B (en) | 1999-02-23 |
AU9538198A (en) | 1999-03-29 |
BR9812043A (en) | 2000-10-03 |
CA2302647A1 (en) | 1999-03-18 |
WO1999013081A1 (en) | 1999-03-18 |
NO20001178D0 (en) | 2000-03-07 |
KR20010023749A (en) | 2001-03-26 |
EP1012290A1 (en) | 2000-06-28 |
JP2001515721A (en) | 2001-09-25 |
HUP0004599A3 (en) | 2002-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW358907B (en) | A computer system and a method of using a DRAM array as a next level cache memory | |
IL133220A0 (en) | Stabilized antibody formulation | |
ZA963737B (en) | Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism. | |
DE69636585D1 (en) | fuel Injector | |
NO304261B1 (en) | Composition comprising a lipophilic compound | |
MX9703063A (en) | Boronic ester and acid compounds, synthesis and uses. | |
FI953080A0 (en) | Alkaline lipase | |
BG103664A (en) | Pharmaceutical forms containing ammoxycillin and clavulanate | |
NO20001178L (en) | Expression of gonadotropins in Dictyostelium | |
EP0817645A4 (en) | Method for treatment of benign prostatic hypertrophy | |
DE59309740D1 (en) | LYOPILIZED, ACTIVE EMULSION | |
HUT65732A (en) | Process for producing peptide compounds first of all lhrh antagonists | |
NZ334949A (en) | Stabilised pharmaceutical composition of quinupristine and dalfopristine with methanesulphonic acid or hydrochloric acid | |
ATE216254T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE AND A CARRIER WITH AT LEAST ONE ESTER-ALPHA-GLYCEROPHOSPHORIC ACID | |
TR199900748A2 (en) | Using combination of osteinductive protein and dorsalizing factor. | |
GB2298955B (en) | Fuel cells | |
DK0742365T3 (en) | Fuel injector | |
Jones | Elias Mann (1750-1825): Massachusetts composer, compiler, and singing master | |
TR199801514A2 (en) | N-Piruvil-L-Prolin �retimi i�in yintem. | |
NO995291L (en) | Expression of fungicide-binding polypeptides in plants to provide fungicide tolerance | |
LV11629A (en) | Cultivated candida old cultures | |
KR970019725U (en) | Gas injector in reactor | |
TW271382B (en) | Process of producing soy sauce added with spirulina | |
KR970041281U (en) | Fuel vaporizer for improving engine power | |
MX9705215A (en) | Methods of inhibiting growth hormone effects. |